BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23780804)

  • 1. Oral mucosal involvement in bullous lupus.
    Anyanwu CO; Ang CC; Werth VP
    Arthritis Rheum; 2013 Oct; 65(10):2622. PubMed ID: 23780804
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral mucosa involvement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
    Aliko A; Alushi A; Tafaj A; Lela F
    Int Dent J; 2010 Oct; 60(5):353-8. PubMed ID: 21141208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral manifestations of patients with lupus erythematosus.
    Brennan MT; Valerin MA; Napeñas JJ; Lockhart PB
    Dent Clin North Am; 2005 Jan; 49(1):127-41, ix. PubMed ID: 15567365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.
    Sanz PG; García Méndez CV; Cueto AL; Silva VB; Walther JC; Diez RA; Martins S; Giannaula RJ
    Rheumatol Int; 2012 Dec; 32(12):4061-3. PubMed ID: 21922339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mucosal ulceration in systemic lupus erythematosus.
    Urman JD; Lowenstein MB; Abeles M; Weinstein A
    Arthritis Rheum; 1978; 21(1):58-61. PubMed ID: 623694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.
    Alishiri GH; Saburi A; Bayat N; Saadat AR; Saburi E
    Clin Rheumatol; 2012 Feb; 31(2):381-4. PubMed ID: 22015937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudolymphomatous tumid lupus erythematosus of the oral mucosa.
    Tallon B; Kaddu S; Cerroni L; Kerl H; Aberer E
    Am J Dermatopathol; 2010 Oct; 32(7):704-7. PubMed ID: 20559118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mucosal lesions in systemic lupus erythematosus--a clinical, histopathological and immunopathological study.
    Jonsson R; Heyden G; Westberg NG; Nyberg G
    J Rheumatol; 1984 Feb; 11(1):38-42. PubMed ID: 6366226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou P; Kukar M; Hersh A
    Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucocutaneous presentation of systemic lupus erythematosus.
    Freites-Martinez A; Aguado-Lobo M; Calderón-Komaromy A; de Pablo NP; Busquets MU; Borbujo J
    J Pediatr; 2014 Sep; 165(3):631. PubMed ID: 24986455
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lupus disease and its oral manifestations].
    Vallois H; Debien J; Merchak M; Commissionat Y
    Actual Odontostomatol (Paris); 1978; (124):513-37. PubMed ID: 751483
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
    Anolik J
    J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al.
    Ramos-Casals M; Díaz-Lagares C; Khamashta MA
    Arthritis Rheum; 2009 Sep; 61(9):1281-2. PubMed ID: 19714598
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic importance of immunofluorescence in oral bullous diseases and lupus erythematosus.
    Nisengard RJ; Jablonska S; Beutner EH; Shu S; Chorzelski TP; Jarzabek M; Blaszczyk M; Rzesa G
    Oral Surg Oral Med Oral Pathol; 1975 Sep; 40(3):365-75. PubMed ID: 1101128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in the treatment of bullous systemic lupus erythematosus.
    Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
    J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient.
    Wang Y; Zhou W; Zhang Z
    Rheumatology (Oxford); 2015 Jan; 54(1):194-5. PubMed ID: 25288787
    [No Abstract]   [Full Text] [Related]  

  • 17. Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus.
    Vital EM; Wittmann M; Edward S; Md Yusof MY; MacIver H; Pease CT; Goodfield M; Emery P
    Arthritis Rheumatol; 2015 Jun; 67(6):1586-91. PubMed ID: 25707733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lupus erythematosus. 1. Etiopathology, pathology and clinical findings with special reference to the oral mucosa].
    Bermejo Fenoll A
    Av Odontoestomatol; 1991 Sep; 7(7):525-37. PubMed ID: 1776985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed?
    Orteu CH; Buchanan JA; Hutchison I; Leigh IM; Bull RH
    Br J Dermatol; 2001 Jun; 144(6):1219-23. PubMed ID: 11422045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers.
    Muñoz-Corcuera M; Esparza-Gómez G; González-Moles MA; Bascones-Martínez A
    Clin Exp Dermatol; 2009 Jun; 34(4):456-61. PubMed ID: 19522982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.